A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)

✍ Scribed by Limaye, Sewanti; Riley, Sarah; Zhao, Sihai; O’Neill, Anne; Posner, Marshall; Adkins, Douglas; Jaffa, Zachary; Clark, John; Haddad, Robert

• Book ID: 123513412
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 375 KB
• Volume: 49
• Category: Article
• ISSN: 1368-8375
• DOI: 10.1016/j.oraloncology.2013.04.010